Skip to main content
FinSpry Logo
FinSpry
NAMS logo
NAMS
(NASDAQ)
NewAmsterdam Pharma Company N.V.
$32.99-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

NewAmsterdam Pharma Company N.V. (NAMS) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for NewAmsterdam Pharma Company N.V. stock.

Analyst Consensus Rating

Investment consensus from 7 professional research analysts

Consensus Rating

Buy
Based on 7 unique analysts
(9 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$49.00
↑ 48.53% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest NAMS Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Debjit Chattopadhyay
Guggenheim
Strong BuyMaintains
$41.00 → $45.00
Steven Seedhouse
Cantor Fitzgerald
BuyReiterates
$49.00
Debjit Chattopadhyay
Guggenheim
BuyMaintains
$41.00 → $45.00
Matt Phipps
William Blair
BuyReiterates
-
Serge Belanger
Needham
Strong BuyMaintains
$46.00 → $48.00
Leonid Timashev
RBC Capital
BuyMaintains
$47.00
James Condulis
Stifel Nicolaus
BuyMaintains
$50.00
Geoff Meacham
Citi
BuyMaintains
$55.00
Leonid Timashev
RBC Capital
BuyMaintains
$44.00 → $47.00

Frequently Asked Questions

What is the analyst consensus rating for NAMS?

The analyst consensus rating for NAMS is "Buy" based on 7 analyst recommendations.

What is the average price target for NAMS?

The average 12-month price target for NAMS is $49.00, representing an upside of 48.5% from the current price of $32.99.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.